LY2874455

LY2874455

Cat. No.: DIA-0230608

Size: 50 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 1254473-64-7
Formula C21H19Cl2N5O2
Molecular Weight 444.31
SMILES CC(OC1=CC=C2[NH]N=C(\C=C\C3=C[N](CCO)N=C3)C2=C1)C4=C(Cl)C=NC=C4Cl
Target VEGFR2
Product Description LY2874455 is a pan-FGFR inhibitor with IC50 of 2.8 nM, 2.6 nM, 6.4 nM, and 6 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively, and also inhibits VEGFR2 activity with IC50 of 7 nM. Phase 1.
Format & Storage
Purity > 99%
Shipping Shipped on dry ice.
Storage Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top